Our Future Health (OFH)
Our Future Health is a prospective, observational cohort study of the general adult population of the United Kingdom (UK). The programme aims to recruit up to 5 million adults (18 years and older) living in the UK, and so far (June 2024) includes over 989,000 participants who have completed baseline. Recruitment began in July 2022, with a focus on recruiting populations who are historically underrepresented in health research. Participants are routinely followed-up through linkage to health and health-related data, and re-contacted for ongoing biological sampling and questionnaires.
Study design
Cohort - research programme, Cohort - open
Number of participants at first data collection
989,132 (participants as of 26 June 2024)
Recruitment is ongoing
Age at first data collection
≥ 18 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2023
Primary Institutions
National Health Service (NHS)
Our Future Health
Profile paper DOI
Not available
Funders
Alnylam Pharmaceuticals, Inc.
Amgen Inc.
Asthma + Lung UK
AstraZeneca
Biogen Inc.
Ongoing?
Yes
Data types collected
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- Self-report questionnaire – online
- None
- None
- Healthcare data
- Mortality data
Engagement
Keywords
